These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 2572205)
1. Treatment of tardive dyskinesia with bromocriptine. A test of the receptor modification strategy. Lieberman JA; Alvir J; Mukherjee S; Kane JM Arch Gen Psychiatry; 1989 Oct; 46(10):908-13. PubMed ID: 2572205 [TBL] [Abstract][Full Text] [Related]
10. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. Bai YM; Yu SC; Lin CC J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949 [TBL] [Abstract][Full Text] [Related]
11. Use of dopamine receptor agonists to reduce dopamine receptor number as treatment for tardive dyskinesia. Alpert M; Friedhoff AJ; Diamond F Adv Neurol; 1983; 37():253-8. PubMed ID: 6134444 [No Abstract] [Full Text] [Related]
12. The effect of dopamine antagonists in spontaneous and tardive dyskinesia. Fog R Psychopharmacology Suppl; 1985; 2():118-21. PubMed ID: 2860655 [TBL] [Abstract][Full Text] [Related]
13. Intermittent neuroleptic therapy and tardive dyskinesia: a literature review. Goldman MB; Luchins DJ Hosp Community Psychiatry; 1984 Dec; 35(12):1215-9. PubMed ID: 6150891 [TBL] [Abstract][Full Text] [Related]